SU850075A1 - Medicine for treating eye adenoviral affection - Google Patents
Medicine for treating eye adenoviral affection Download PDFInfo
- Publication number
- SU850075A1 SU850075A1 SU731904847A SU1904847A SU850075A1 SU 850075 A1 SU850075 A1 SU 850075A1 SU 731904847 A SU731904847 A SU 731904847A SU 1904847 A SU1904847 A SU 1904847A SU 850075 A1 SU850075 A1 SU 850075A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- adenoviral
- medicine
- affection
- treating eye
- treatment
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
(54) СРЕДСТВО ДЛЯ ЛЕЧЕНИЯ АДЕНОВИРУСНЫХ ПОРАЖЕНИЙ ГЛАЗ(54) MEANS FOR THE TREATMENT OF ADENOVIRAL EYE DAMAGES
1one
Изобретение относитс к медицине, а именно к лечению аденовирусных поражений глаз в офтальмологической практике..The invention relates to medicine, namely to the treatment of adenoviral eye lesions in ophthalmic practice.
Известно применение полиакриламида в качестве коагул нта (флокул нта; в цветной металлургии, химической промышленности и виноделии 1 .The use of polyacrylamide as a coagulant is known (flocculating; in nonferrous metallurgy, chemical industry and winemaking 1.
Цель изобретени - расширение ассортимента средств дл лечени аденовирусных поражений глаз.The purpose of the invention is to expand the range of products for the treatment of adenoviral eye lesions.
Указанна цель достигаетс тем, что в качестве средства дл лечени аденовирусных поражений глаз примен ют 1%-ный раствор полиакриламида.This goal is achieved by using a 1% polyacrylamide solution as a treatment for adenoviral eye damage.
Полиакриламид представл ет собой белый аморфный порошок без запаха, хорошо растворимый в воде при комнатной температуре. 1%-ный раствор полиакриламида примен ют местно в виде инстилл ций раствора или одноразовых аппликаций пленок 1-3 раза в сутки.Polyacrylamide is a white, odorless, amorphous powder, soluble in water at room temperature. A 1% polyacrylamide solution is applied topically in the form of solution instillations or disposable film applications 1–3 times per day.
Проведенные клинические наблюдени над 41 больным аденовирусным койьюнктивитом показали, что 1%-ный раствор полиакриламида хорошо переноситс больными и не обладает побочным нежелательным действием в виде токсических и аллергических реакций .Clinical observations of 41 patients with adenoviral coyuncture have shown that a 1% solution of polyacrylamide is well tolerated by patients and does not have adverse side effects in the form of toxic and allergic reactions.
Предлагаемый препарат не обладает антигенными инфекционными и токсическими свойствами.The proposed drug does not possess antigenic, infectious and toxic properties.
Средн продолжительность лечени (в дн х) полиакрилгмидом больных аденовирусным коньюнктивитом статистически достоверно сокращалась более The average duration of treatment (in days) of polyacrylamide in patients with adenoviral conjunctivitis was statistically significantly reduced by more
10 чем в два раза по сравнению ро сроками лечени известными средствами и составл ет 6,8 0,5 дн по сравнению с 19,,0 и 15,7i2,0 дн ми.10 times as compared with the terms of treatment by known means and amounts to 6.8 0.5 days compared with 19, 0 and 15.7 and 2.0 days.
Предлагаемый препарат вл етс The proposed drug is
15 высокоэффективным и позвол ет расширить ассортимент средств дл лечени аденовирусных поражений глаз.15 is highly effective and allows you to expand the range of products for the treatment of adenoviral eye lesions.
2020
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU731904847A SU850075A1 (en) | 1973-03-23 | 1973-03-23 | Medicine for treating eye adenoviral affection |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU731904847A SU850075A1 (en) | 1973-03-23 | 1973-03-23 | Medicine for treating eye adenoviral affection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU850075A1 true SU850075A1 (en) | 1981-07-30 |
Family
ID=20548715
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU731904847A SU850075A1 (en) | 1973-03-23 | 1973-03-23 | Medicine for treating eye adenoviral affection |
Country Status (1)
| Country | Link |
|---|---|
| SU (1) | SU850075A1 (en) |
-
1973
- 1973-03-23 SU SU731904847A patent/SU850075A1/en active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2284294A1 (en) | ASSISTANCE DEVICE FOR THE TREATMENT OF MEDICAL EMERGENCIES ENCOUNTERED ESPECIALLY IN THE PRACTICE OF MEDICINE | |
| EA200100524A1 (en) | AMIDES OF ANTRANILIC ACID AND THEIR APPLICATION AS MEDICINES | |
| BE873695A (en) | METHOD AND PREPARATION FOR THE INACTIVATION OF VIRUSES AND APPLICATIONS OF THE latter FOR PHARMACEUTICAL COMPOSITIONS AND TREATMENT OF FOOD MATERIALS | |
| FR2378523A1 (en) | ACNE TREATMENT MEDICINE | |
| FR2361901A1 (en) | NUCLEOTIDES SUBSTITUTION DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING THESE SUBSTANCES | |
| DE69019533D1 (en) | TREATMENT OF HIV INFECTIONS AND USEFUL LINKS THEREFOR. | |
| NO902800L (en) | PROCEDURE FOR THE PREPARATION OF 11BETA-ARYL-4-OESTERS. | |
| BE821942A (en) | ADSORPTION PRODUCT FOR THE TREATMENT OF INDUSTRIAL WASTEWATER | |
| FR2333807A1 (en) | NEW DERIVATIVES OF FUSIDIC ACID, USEFUL IN PARTICULAR AS AN ANTIBACTERIAL IN HUMAN AND VETERINARY MEDICINE AND THEIR PREPARATION PROCESS | |
| FR2451745A1 (en) | PROCESS FOR THE PREPARATION OF IMMUNOGLOBULIN FOR INTRAVENOUS ADMINISTRATION | |
| DK0594770T3 (en) | Ophthalmological mixtures | |
| FR2384779A1 (en) | NEW OXIMES DERIVED FROM 3-CHLORO OR 3-METHOXY 7-AMINO THIAZOLYL ACETAMIDO CEPHALOSPORANIC, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICINAL PRODUCTS | |
| SU850075A1 (en) | Medicine for treating eye adenoviral affection | |
| ES2066914T3 (en) | FACTORS A1, A2, A3 AND H OF THE ANTIBIOTIC GE 2270. | |
| ES2071143T3 (en) | FACTORS B1, B2, C1, C2, D1, D2, E AND T OF THE ANTIBIOTIC GE 2270. | |
| ATE40793T1 (en) | PHARMACEUTICAL PREPARATION FOR THERAPEUTIC TREATMENT OF RHEUMATIC DISEASES. | |
| ATE3552T1 (en) | PROCESS FOR THE PREPARATION OF PHOSPHONO-HYDROXY-ACETIC ACID AND SALTS THEREOF AND AUTIVIRALS CONTAINING THEM. | |
| ATE5256T1 (en) | PHENYLPIPERAZIN DERIVATIVES OF 1,3,4OXADIAZOLYLPENOLS, THEIR PREPARATION AND THERAPEUTIC AGENTS CONTAINING THEM. | |
| ATE110568T1 (en) | PHARMACEUTICAL PREPARATION FOR TREATMENT OF CATARACT. | |
| FR2421173A1 (en) | 2- (4-ETHYLPIPERAZINO) -4-PHENYLQUINOLEINE AND ITS SALTS, USEFUL IN PARTICULAR AS ANTIDEPRESSANTS, AND THEIR PREPARATION PROCESS | |
| BE904846A (en) | 11BETA-SUBSTITUTED STEROIDS USEFUL IN PARTICULAR IN THE TREATMENT OF HORMONO-DEPENDENT TUMORS AND METHOD FOR THE PRODUCTION THEREOF. | |
| FR2451918A1 (en) | 6-ARYL PYRIMIDINE COMPOUNDS, THEIR PREPARATION AND THEIR USE AS MEDICINAL PRODUCTS | |
| FR2469712A1 (en) | ABRINE-CONTAINING IMMUNOPOTENTIALIZER AND THERAPEUTIC COMPOSITION CONTAINING THE SAME | |
| AT294046B (en) | Process for the preparation of N, N'-bis [2- (3 ', 4'-dihydroxyphenyl) -2-hydroxyethyl] -hexamethylenediamine, its optically active forms and the salts thereof | |
| BE816170A (en) | OXYGENIC HETEROCYCLIC DERIVATIVES FOR USE AS MEDICINAL PRODUCTS FOR THE TREATMENT OF DELAYED HYPERSENSITIVITY |